BOSTON SCIENTIFIC CORP is 2.4x more valuable than DEXCOM INC by market capitalization ($69.72 B vs $29.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DXCM | BSX |
|---|---|---|
| Market cap | $29.08 B | $69.72 B |
| US-listed rank | #479 | #249 |
| Revenue (latest FY) | $4.66B | $20.07B |
| Net income (latest FY) | $836.30M | - |
| Net margin | 17.9% | - |
| P/E (trailing FY) | 34.8 | - |
| SEC filings | 2,566 | 1,009 |
BOSTON SCIENTIFIC CORP is 2.4x more valuable than DEXCOM INC by market capitalization ($69.72 B vs $29.08 B).
In their latest fiscal years, DEXCOM INC reported $4.66B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: DEXCOM INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.